Drug Makers Sued Over Cholesterol Drug
Lek, a wholly-owned subsidiary of Novartis, has filed civil action against US drug maker Bristol-Myers Squibb and Watson Pharmaceuticals for willful and deliberate violation of two patents.
The suit, filed December 29, 2006 in the US District Court for the Eastern District of Texas, claims the drug makers knew, or should have known, about the patents.
The patents were issued to Lek, in May 2005 and...
To view the full article, register now.